A comparison between two brine shrimp assays to detect in vitro cytotoxicity in marine natural products by Carballo, José Luis et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC Biotechnology
Open Access BMC Biotechnology  2002,  2 x Methodology article
A comparison between two brine shrimp assays to detect in vitro 
cytotoxicity in marine natural products
José Luis Carballo*1, Zaira L Hernández-Inda1, Pilar Pérez1 and 
María D García-Grávalos2
Address: 1Instituto de Ciencias del Mar y Limnología, UNAM. Estación Mazatlán. Apartado Postal 811. Mazatlán 82000. México and 2Pharma-
Mar SA, C/ de la Calera 3, (Tres Cantos, Madrid), España
E-mail: José Carballo* - carballo@ola.icmyl.unam.mx; Zaira L Hernández-Inda - zaira@ola.icmyl.unam.mx; 
Pilar Pérez - pilar@ola.icmyl.unam.mx; María D García-Grávalos - lgarciagravalos@pharmamar.com
*Corresponding author
Abstract
Background:  The brine shrimp lethality assay is considered a useful tool for preliminary
assessment of toxicity. It has also been suggested for screening pharmacological activities in plant
extracts. However, we think that it is necessary to evaluate the suitability of the brine shrimp
methods before they are used as a general bio-assay to test natural marine products for
pharmacological activity.
Material and Methods: The bioactivity of the isopropanolic (2-PrOH) extracts of 14 species of
marine invertebrates and 6 species of macroalgae was evaluated with the shrimp lethality assay
(lethality assay), as well as with another assay based on the inhibition of hatching of the cyst
(hatchability assay). The extracts were also assayed for cytotoxicity against two human cell lines,
lung carcinoma A-549 and colon carcinoma HT-29, in order to assess the sensitivity of the shrimp
assays to detect cytotoxic activity.
Results: Two sponges (Hyatella sp, Dysidea sp.), two gorgonians (Pacifigorgia adamsii, Muricea sp.),
one tunicate (Polyclinum laxum), and three echinoderms (Holothuria impatiens, Pseudoconus californica
and Pharia pyramidata) showed a strong cytostatic (growth inhibition) and cytotoxic effect. The
hatchability assay showed a strong activity in 4 of the species active against the two human cell lines
tested (Hyatella sp, Dysidea sp., Pacifigorgia adamsii and Muricea sp.), and the lethality assay also
showed a high lethality in 4 of them (Pacifigorgia adamsii, Muricea sp., Polyclinum laxum, and Pharia
pyramidata). Each bioassay detected activity in 50% of the species that were considered active
against the two human cell lines tested. However, the simultaneous use of both bioassays increased
the percentage to 75%.
Conclusions: Our results seem consistent with the correlation previously established between
cytotoxicity and brine shrimp lethality in plant extracts. We suggest using both bioassays
simultaneously to test natural marine products for pharmacological activity.
Background
The shrimp lethality assay was proposed by Michael et al.
[1], and later developed by Vanhaecke et al. [2], and Sleet
and Brendel [3]. It is based on the ability to kill laborato-
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ry-cultured Artemia nauplii brine shrimp. The assay is con-
sidered a useful tool for preliminary assessment of toxicity
[4], and it has been used for the detection of fungal toxins
[5], plant extract toxicity [6], heavy metals [7], cyanobac-
teria toxins [8], pesticides [9], and cytotoxicity testing of
dental materials [10].
On the other hand, although most researchers have made
use of the hatched nauplii, other assays based on the inhi-
bition of hatching of the cyst (encased embryos that are
metabolically inactive) have also been used [11].
We think that it is necessary to evaluate the suitability of
both methods before the brine shrimp method is used as
a general bio-assay technique to test natural marine prod-
ucts for biological and pharmacological activity.
Our aim was to assess the bioactivity of organic extracts
from 20 species of marine organisms (mainly inverte-
brates) with two Artemia brine shrimp assays, and then
compare the results with those obtained for cytotoxic ac-
tivity against two human cell lines: lung carcinoma A-549
and colon carcinoma HT-29.
For this purpose, we developed a method based on the
percentage of hatching of the cyst which was incubated in
a medium with different concentrations of organic ex-
tracts. Toxicity was measured by comparing the percent-
age of hatched nauplii to a control.
Our study is part of a program for screening a variety of bi-
ological activities in marine fauna in order to find new
substances with potential pharmaceutical applications.
Results and discussion
Cytotoxicity assay against human lung carcinoma (A-549) 
and human colon carcinoma (HT-29)
Only the extracts which showed GI values higher than
60% at the three concentrations tested were considered
active. The species that presented the highest cytotoxicity
at the highest concentration tested were the sponges Hyat-
ella sp. (161% Gl for A-549, and 129% for HT-29) and
Dysidea sp. (106 and 88% GI), the cnidarian Pacifigorgia
adamsii (127 and 86% GI), the tunicate Polyclinum laxum
(87 and 102% GI), the equinoderm Pseudoconus californica
(122 and 139% GI), and the macroalgae Colpomenia tuber-
culata (91 and 91% GI) (Table 1). All of them had values
greater than 60% GI at the three concentrations tested.
The GI data obtained in these species allow us to predict
their potential not only because of the cystostatic effect,
but in terms of potential for tumor reduction (values
higher than 100%).
Brine shrimp bioassays
Only a few species were bioactive against the brine shrimp
bioassays at 10 and 100 µg de extract per ml, and a low re-
lationship between the brine shrimp bioassays and the cy-
totoxicity assays was found. However, most of the
invertebrates presented toxicity in some of the bioassays
at 1000 µg/ml in a way that was consistent with the cito-
toxicity results. The macroalgae was the group where least
activity was detected. A strong hatch inhibition (hatcha-
bility assay) was present in the extracts of the sponges Hy-
atella sp. (51%), Mycale parishii (64%) and Dysidea sp.
(50%), and in the extracts of the gorgonians Lophogorgia
sp. (81%), Pacifigorgia adamsii (76%) and Muricea sp.
(89%). After 12 h of exposure, the percentage of active
species increased very slightly. After 24 h of exposure there
were no significant changes in the activity of the extracts,
although a few species such as Muricea sp. and Lophogorgia
were more active at 48 h than at 24 h.
On the other hand, a high lethality was found in the ex-
tracts of the gorgonians Pacifigorgia adamsii (68%), Muri-
cea sp. (83%), the tunicate Polyclinum laxum (96%) and
the echinoderms Toxopneustes roseus (96%), Isostichopus
fuscus (96%) and Pharia pyramidata (93%) (Table 1). In
this case, activity increased significantly with up to 48 h of
exposure.
With respect to the effect of the time of exposure, in the
hatchability test the highest percentage of toxicity was de-
tected at 12 h or 24 h of exposure, and significant changes
in toxicity were not detected in subsequent times of expo-
sure. The very low hatching rate detected after the 12 h
treatment was probably due to an alteration in the devel-
opment of Artemia embryos. It has been shown that Ar-
temia is highly vulnerable to toxins at the early
developmental stages [12,13]. In contrast, in the brine
shrimp lethality test, maximum sensibility was reached af-
ter 48 h of exposure (the oldest age class tested by us) [14].
At this stage in their life cycle the nauplii have reached
their second and third instar and exhibit their greatest sen-
sitivity to test compounds [15].
The hatchability test detected toxicity in a number of spe-
cies similar to the lethality test, but seemed less sensitive
to detect toxicity of macroalgae extracts. In general, the
groups with the highest percentage of toxic species, and
with the most toxic extracts, were the invertebrates. Some
species such as the echinoderms, the sponges Mycale pa-
rishii, Dysidea, sp, and the gorgonians Muricea sp. etc, sig-
nificantly lowered hatching in the hatchability test,
interfering with normal development of the nauplii. The
echinoderms  Toxopneustes roseus,  Isostichopus fuscus, etc.
presented a high lethality (almost 100%).BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/17
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The high incidence of toxicity in sponges and echino-
derms seems to be an effective defense mechanism against
many predation fishes, which increases closer to the trop-
ics (almost 100% of all species tested) [16].
For the past 30 years, the Artemia nauplii have been used
to detect general toxicity [17], in teratology screens
[3,13,18,19] and in ecotoxicology [12,17]. From a phar-
macological point of view, a good relationship has been
found with the brine shrimp lethality test to detect antitu-
moral compounds in terrestrial plant extracts [4,20,21].
These two bioassays show that standard tests employing
organisms such as brine shrimp are useful in identifying
metabolites with a high potential for activity against ma-
rine organisms. Our results show that the shrimp hatcha-
bility test together with the lethality test could be an easy
bioassay to screen marine natural products.
Methods
Collection and preparation of extracts
4 species of sponges, 3 gorgonians, 6 echinoderms, 1 tu-
nicate, and 6 macroalgae (Table 1) were collected by snor-
keling and scuba diving from low tide to a depth of 20 m
along the Mexican Pacific coast. The specimens of each
species were freeze-dried and ground together. The
lyophilized material (2–5 g) was extracted three times
with 2-PrOH (1/20) w/v. The extracts were evaporated un-
der reduced pressure and dissolved in acetone/methanol
(1:1) to prepare the stock solution.
Preparation of the bioassays
The tests were conducted in multiwell plates in filtered
(0.45 µm pore diameter) and sterilized seawater (final
volume 5 ml). Each of the extracts for each species was
tested at 1000, 100 and 10 µg of extract per ml. The con-
centrations were obtained by transferring the correspond-
ing volume from the stock solution to different wells for
evaporation [21]. After evaporation, 5 ml of seawater were
added to each well with gentle shaking to ensure that the
compounds diffused adequately in the aqueous solution.
Four replicates were used for each treatment and control.
The control was performed by adding the solvent used to
dissolve the extracts in the assays, and it was allowed to
evaporate. Before the assays, the average time of appear-
ance of the first free nauplii and the subsequent develop-
Table 1: Toxicity of the isopropanolic extracts against lung (A-549), colon carcinoma (HT-29), and brine shrimp assays
A-549 HT-29 HI-12 h HI-24 h HI-48 h M-12 h M-24 h M-48 h
Sponges
Chondrosia tenochca 16 22 19 15 11 0 0 77
Hyatella sp. 161 129 28 51 46 13 15 40
Mycale parishii 42 54 4 6 2 6 4 5 1 0 1 0
Dysidea sp. 106 88 35 50 50 0 3 59
Gorgonians
Lophogorgia sp. 33 26 51 72 81 0 0 0
Pacifigorgia adamsii 127 86 56 72 76 8 68 68
Muricea sp. 93 131 42 64 89 40 83 83
Tunicates
Polyclinum laxum 87 102 3.4 67 96.5 95.5
Echinoderms
Toxopneustes roseus 14 14 8.4 24.4 29.6 17 96.5 95.5
Isostichopus fuscus 31 13 8.4 24.4 29.8 32 91.5 95.5
Holoturia impatiens 181 84 4.3 23.7 60
Pseudocus californica 122 139 17.9 27.8 30 1.5 18 58
Phataria unifascialis 29 10 5.6 8.8 0.2 1.8 8.7 20
Pharia pyramidata 194 88 17.9 27.8 30 1.5 0.5 93
Macroalgae
Colpomenia tuberculata 91 91 4.4 12.8 19.1 0 8.3 8.3
Enteromorpha intestinalis 2 47 8 20.3 20.6 1.8 5 38.1
Gelidiopsis tenuis 81 91 5.6 8.5 18.6 0 3.33 0.8
Ralfsia hesperia 11 7 8 5.1 0.9 1.8 2.5 13.1
Ceramium sp. 4 5 7.4 18 24.1 0 0.8 0.8
Codium dichotomum 110 -9 2.6 0.5 2.8 0 0 0
The percentage of growth inhibition at 50 µg/ml is shown below A-549 and HT-29. The percentage of hatch inhibition, and percentage of mortality 
at 1000 µg/ml at 12, 24 and 48 h of exposure are shown below HI (brine shrimp hatchability test)and M (brine shrimp lethality test).BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/17
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mental stages was calculated. The first cysts hatched
approximately after 12 h of incubation (average time); the
maximum percentage of instar II (55.33%) appeared 12 h
later (24 h after the start of incubation). All the tests were
performed in a temperature-controlled room at 28°C, un-
der a continuous light regime. The extracts were subjected
to the following tests:
Brine shrimp hatchability test
The brine shrimp hatchability test is based on Migliore et
al. [11]. They calculated the hatch, harvesting the free nau-
plii from 1 g of cysts on a Millipore 45 µm filter, weighed
and placed in a desiccator at 60 C for 24 h to obtain the
dry weight. In our case, the percentages of hatchability
were calculated by comparing the number of free nauplii
in each treatment with the number of free nauplii in the
control and the whole procedure was standardized (see
below).
Following the procedure in Amat [22], 0.5 g of dried cysts
were separated from their shells using the commercial
brine shrimp hatchers solution. After that, the cysts were
hatched in seawater (1 g cyst per liter) at 28°C, under con-
ditions of continuous illumination and strong aeration.
After 2 h aliquots measuring 250 µl were placed in each
well where the extracts had previously been deposited,
and they were incubated at the same conditions of tem-
perature and illumination under gentle shaking. After 12,
24 and 48 h of exposure the free nauplii were counted un-
der a stereoscopic microscope. The percentages of hatcha-
bility were calculated by comparing the number of free
nauplii in each treatment with the number of free nauplii
in the control. Later the percentage of hatch inhibition
(%HI) was calculated as: % HI = % hatchability in the
control - % hatchability in each treatment.
Brine shrimp lethality test
Dried cysts were performed as indicated above, and incu-
bated (1 g cyst per liter) in a hatcher at 28–30°C with
strong aeration, under a continuous light regime. Approx-
imately 12 h after hatching the phototropic nauplii were
collected with a pipette from the lighted side and concen-
trated in a small vial. Ten brine shrimp were transferred to
each well using adequate pipettes. Each test consisted of
exposing groups of 10 Artemia aged 12 h to various con-
centrations of the toxic compound. The toxicity was deter-
mined after 12 h (mainly nauplii in instar I/II), 24 h
(nauplii in instar II/III) and 48 h (mainly nauplii in instar
III/IV) of exposure.
The numbers of survivors were counted and percentage of
deaths were calculated. Larvae were considered dead if
they did not exhibit any internal or external movement
during several seconds of observation.
The larvae did not receive food. To ensure that the mortal-
ity observed in the bioassay could be attributed to bioac-
tive compounds and not to starvation; we compared the
dead larvae in each treatment to the dead larvae in the
control. In any case, hatched brine shrimp nauplii can sur-
vive for up to 48 h without food [15] because they still
feed on their yolk-sac [10]. However, in cases where con-
trol deaths were detected, the percentage of mortality (%
M) was calculated as: % M = percentage of survival in the
control - percentage of survival in the treatment.
Bioassays for cytotoxicity
The cytotoxicity of the extracts was assessed employing
two human cell lines: lung carcinoma (A-549), and colon
carcinoma (HT-29). A colorimetric type of assay using a
sulforhodamine B (SRB) reaction was adapted for a quan-
titative measurement of cell growth and viability, follow-
ing the technique described by Skehan et al. [23]. Cells
were seeded in 96-well microtiter plates, at 5 × 103 cells
per well in aliquots of 190 µl, and they were allowed to at-
tach to the plate surface by growing in a drug free medium
for 18 hours. Afterward, samples were added in aliquots
of 10 µl (dissolved in DMSO/H2O 1:9). After 48 hours of
exposure, the cytotoxicity was measured by the SRB meth-
odology: cells were fixed by adding 50 µl of cold 50% (w/
v) trichloroacetic acid (TCA), and incubating for 60 min-
utes at 4°C. Plates were washed with deionized water and
dried. One hundred µl of SRB solution (0.4% w/v in 1%
acetic acid) was added to each microtiter well, and incu-
bated for 10 minutes at room temperature. Unbound SRB
was removed by washing with 1% acetic acid. Plates were
air dried and bound stain was dissolved with Tris buffer.
Optical densities were read on an automated spectropho-
tometric plate reader at a single wavelength of 490 nm.
Data analysis was generated automatically by LIMS imple-
mentation at PharmaMar and some parameters for cellu-
lar responses were calculated. The activity of the
isopropanolic extracts was given in % GI (growth inhibi-
tion) for each concentration tested (50, 17 and 5 µg per
ml). Values could be as follows:
- negative GI = no growth inhibition (NOT ACTIVE)
< 50% GI = week growth inhibition (NOT ACTIVE)
50 to 100% GI = moderate to high growth inhibition (AC-
TIVE, growth inhibition effect)
100% GI = Total growth inhibition (ACTIVE, cytostatic ef-
fect)
>100% GI = Cell killing (ACTIVE, cytotoxic effect).BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/17
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